Advent Technologies Holdings, Inc. (ADN)
NCM · Common · CUSIP 00788A105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ADN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
00788A105 (prev. 00165R101 )
Market Cap
Micro Cap
IPO
11/15/2018
Previous Symbol
AMCI (changed 2/4/2021)
Previous Name
AMCI Acquisition Corp.
Business: Advent Technologies’ mission is to become the leading provider of high-temperature proton exchange membranes (“HT-PEM”) and HT-PEM based membrane electrode assemblies (“MEA”), which are critical components used in fuel cells, and other electrochemistry applications such as electrolyzers, flow batteries, and IoT sensors. Advent’s principal focus is on the fuel cell market, and Advent’s goal is to use its products and technology to address pressing global climate needs.
Notes: February 4, 2021-- Advent Technologies Inc. (“Advent”), an innovation-driven company in the fuel cell and hydrogen technology space, and AMCI Acquisition Corp. (NASDAQ: AMCI) (“AMCI”), a special purpose acquisition company, today announced that they have completed their previously announced business combination (the “Business Combination”). The combined company, Advent Technologies Holdings, Inc. (“Advent” or the “Company”), will begin trading on Nasdaq tomorrow, February 5, 2021, under the ticker symbol “ADN”.

Company Contact

CEO
Vasilis Gregoriou
CFO
Naiem Hussain
Headquarters
5637 La Ribera St., Suite A Livermore, CA 94550
Phone
617-655-6000
Investor Relations
724-672-4319 · ir@advent.energy
Email Form
Request Form »
SEC EDGAR Filings
View filings »